Introduction
High-density lipoproteins (HDL) play an important role in the transport of cholesterol from extrahepatic tissues to the liver, a process called reverse cholesterol transport.
This role of HDL has been reinforced by studies in cultured cells, showing that HDL can accept cholesterol from cells in a process regulated by their cholesterol status [1, 2] . The exact mechanism of this process is still unknown.
Specific lipoprotein receptors [2-41, desorption of unesterified cholesterol from the plasma membrane followed by diffusion through the water phase [5-71 and [6, 7] . Mendel [16, 17] measured a molecular mass of approx. 10 to 16 kDa for the functional unit of the putative HDL binding protein using radiation inactivation, while ligand blotting experiments point to a binding protein molecular mass ranging from 78 to 110 kDa [ll-151. It has been shown that liver and steroidogenic tissues are especially active in metabolizing HDL particles. Cholesteryl esters from HDL are taken up at a greater fractional rate than apo A-I, i.e., cholesteryl esters are taken up without parallel uptake of HDL-apo A-I [18-201 in a process called selective uptake.
It is known that plasma HDL consists of a heterogeneous population of lipoprotein particles. The various HDL subclasses have different densities, which are used for the isolation of HDL, and HDL, by ultracentrifugation. Within these subfractions, particles with diameters ranging from 8 to 11 nm can be detected using gradient gel electrophoresis [21, 22] . After subfractionation of HDL in seven or nine subfractions by density gradient ultracentrifugation apo A-I and apo A-II were abundant in all subfractions [23] . Chromatography on specific antibody columns is the method of choice for the isolation of HDL particles with different apolipoprotein composition [23, 24] . HDL consists of at least two types of particles: lipoproteins containing both apo A-I and apo A-II (LP A-I/A-II) and lipoprotein particles with apo A-I but without apo A-II (LP A-I). In the present study we characterized the chemical compositions of LP A-I and LP A-I/A-II  and  measured their size by gel filtration. This is the first report on the binding and uptake of LP A-I and LP A-I/A-II by the human hepatoma cell-line HepG2.
Materials and Methods
Anti-apo A-I and anti-apo A-II immuno affinity chromatography columns, as well as the antibodies used for ELISA of apolipoproteins, were generously provided by Prof. J.C. Fruchart and Dr. P. Puchois from the Institut Pasteur in Lille (France).
Blood was collected from healthy, normolipidemic volunteers in tubes containing EDTA (final concentration 1.5 mg/ml) and cooled on ice immediately. The subjects were starved overnight.
Plasma was collected by centrifugation for 1.5 min at 1500 X g,,, and 4" C. All following isolation procedures were performed at 4 o C. Plasma HDL was obtained by gel filtration of 2 ml plasma using a Superose 6 column (prep. grade, 1.6 x 50 cm, Pharmacia, Uppsala, Sweden) as described in [25] . The elution buffer consisted of 0.9% NaCl, containing 2 mM sodium phosphate (pH 7.4) 5 mM EDTA and 0.02% NaN,. Plasma cholesteryl (esters), phospholipids and triacylglycerols were eluted with high recoveries [25] . The HDL fractions obtained after two runs (2 ml of plasma each) were pooled and applied on a combination of a Sephadex column (G25 Fine, 1.6 X 35 cm, Pharmacia, Uppsala, Sweden) directly connected with a heparin-Sepharose column (1.3 x 29 cm), and eluted with 2 mM sodiumphosphate buffer (pH 7.4). containing 0.1% NaN, [26] . No apo E was detectable in the HDL fraction obtained after this procedure using ELISA as described in [27] .
The next isolation steps consisted of immuno-affinity column chromatography, as described by Barbaras et al. [24] . For isolation of the LP A-I/A-II particles, the apo E-free HDL fraction was passed through the immunoaffinity column with anti-apo A-II (flow 10 ml/h). The eluate was controlled for remaining apo A-II using a highly sensitive ELISA technique [27] . The resulting apo A-II-free HDL was subsequently applied on an anti-apo A-l column, which bound ail LP A-I. Both antibody columns were washed with 150 ml of 0.9% NaCl containing 0.1 M sodiumphosphate (pH 7.4) 0.1% EDTA and 0.1% NaN,, followed by 30 ml 0.5 M NaCl with 10 mM sodium phosphate (pH 7.4) to elute non-specifically bound material. The HDL-subfractions were eluted with 30 ml 3 M sodiumthiocyanate, immediately followed by gel filtration on a Sephadex column (G25 Coarse, 2.6 X 60 cm, Pharmacia, Uppsala, Sweden). Both subfractions were concentrated by pressure dialysis using YMlO membranes (Amicon, Danvers, MA) and dialyzed against 0.9% NaCl with 10 mM sodium phosphate (pH 7.4) and 1 mM EDTA.
Labeling of LP A-l and LP A-I/A-II with "'I or [3HJcholesteryl lino/eyI ether
The HDL-subfractions were iodinated using the ICI method (with Na'"'1 from Amersham International, U.K.), as described previously [28] . Labelling efficiency was 52 to 68% and the iodine/protein ratio ranged from 0.58 to 0.73. Less than 1% of the radioactivity of the preparations was free (non-precipitable with trichloroacetic acid L-a-phosphatidylcholine P-5388 from Sigma, St. Louis, MO. U.S.A.) in the presence of 0.01% EDTA and enough purified CETP to give the CETP activity level present in human plasma. 1 mM IAA was added to inhibit LCAT. The amount of phosphatidylcholine used during the incubations was kept as low as 1% of the total HDL-phospholipids.
in order to prevent changes in the phospholipid content of the particles. Lipoproteins and CETP were separated after incubation by density gradient ultracentrifugation and the HDL-subfractions were reisolated from the density range 1.06331.21 g/ml. The specific radioactivity ranged from 50 to 80 dpm/ng protein. After labelling, the subfractions were dialyzed against 0.9% NaCl containing 10 mM sodiumphosphate (pH 7.4) and 1 mM EDTA. If necessary, the fractions were dialyzed against the cell culture medium prior to the binding experiments.
Cell culture
HepG2 cells were cultured in DMEM/FlO' (1 : 1) medium (DMEM was purchased from Flow Laboratories and FlO+ from Gibco), supplemented with Lglutamine, penicilline/streptomycine and 10% FCS, at 37°C in 95% air and 5% COz. Cells were plated in multiwell dishes (35 mm, 0.5-1.0. lo6 cells/well) 3 d prior to each experiment.
After 2 d the medium was removed, cells were rinsed three times with 0.9% NaCl containing 10 mM sodiumphosphate (pH 7.4) and new medium, containing either 10% FCS or 2% BSA (A-4378, Sigma, St. Louis, MO), was added to the wells. After a preincubation period of 24 h the cells were ready for use in the binding experiments.
At that time cells were near confluency.
Lipoprotein binding studies -80°C. After three washes with cold 0.9% NaCl, containing 10 mM sodium phosphate (pH 7.4) the cells were placed on ice and 1 ml test medium was added. The test medium used was culture medium (see above) in which the FCS was replaced by 2% BSA. The amount of iodinated lipoproteins in the test media ranged from 0 to 20 pg protein/ml.
Non-specific binding was measured after addition of 100 pg protein/ml of unlabelled LP A-I or LP A-I/A-II.
This low amount of HDL-protein was used for practical reasons. Addition of high concentrations (e.g., 1 mg protein/ml) is impractical, due to the limited capacity of the antibody columns. Therefore, we measured an apparent 'specific binding', which is somewhat lower than the real specific binding. Competition was measured using 5 pg iodinated lipoprotein LP A-I or LP A-I/A-II per ml medium with O-175 pg/ml unlabelled protein of the competing lipoprotein particle. For all experiments the cells were incubated for 4 h at 4°C under a H,O-saturated atmosphere with 5% COz and 95% air. After incubation the dishes were placed on ice, the medium was removed and the cells were washed three times with 0.2% BSA in 0.9% NaCl with 50 mM Tris-HCl (pH 7.4) to remove non-specifically bound material. Then the cells were rinsed three times with 0.9% NaCl containing 50 mM Tris-HCl (pH 7.4). The cell protein was dissolved in 2 ml 1 M NaOH. The cell-bound radioactivity was measured using a gamma counter, and protein was measured according to Lowry et al. [30] .
The apo A-I and apo A-II concentrations were determined by immuno-electrophoresis [32] . The molar ratio of apo A-I to apo A-II was calculated using a M, of 2.8. lo4 and 1.7. lo4 for apo A-I and apo A-II, respectively.
Particle weights of LP A-I and LP A-I/A-II were determined by gel filtration on a Aca 34 column (Ultrogel, Reactifs IBF, Villeneuve-la-Garenne, France [33] . Results were regarded as significantly different if P < 0.05.
Results

Binding plus uptake of iodinated or [3H]cholesteryl ether-labelled
LP A-I and LP A-I/A-II were measured at 37°C at a concentration of 20 pgg/ml of protein. This binding plus uptake will be referred to as total cell association. The overall procedure for these experiments at 37°C is identical with that described above for the experiments at 4°C. Table I 
Lipoprotein analyses
The protein content of the HDL-subfractions was measured according to [30] mean spherical particle radius of 6.2 nm and a smaller peak with a radius of approx. 5.2 nm. The profile of LP A-I/A-II shows only one peak ( Fig. 1 ) corresponding with a mean particle radius of 5.5 nm.
No apo A-II could be detected in the LP A-I fraction on SDS-polyacrylamide gel electrophoresis (Fig. 2) . There was only a very small amount of contaminating protein degradation product of apo A-I. Evidence in favor of a high sensitivity for proteolytic degradation in specific HDL subfractions has been published recently [34] . ELISA assays showed that the percentage of apo A-II in the LP A-I subfraction is less than O.l%, apo C-III (quantitatively the most important apo C in HDL) ranged from l-3%, and apo E was less than 0.5% of total apolipoprotein.
TABLE II
Competition of the binding of iodinated LP A-I and iodinated LP A-I/A-II by unlabelled LP A-I/A-II or LP A-I in HepC2 cells at 4°C
The molar ratio of apo A-I/ape A-II in the LP A-I/A-II subfraction, measured in delipidated samples, was 1.4 -t 0.2 (mean * S.E.M., n = 5). Fig. 3 shows an autoradiogram obtained after SDSpolyacrylamide gel electrophoresis of iodinated LP A-I and LP A-I/A-II.
Only very little radioactivity is present in proteins other than apo A-I or apo A-II. Both HDL-subfractions showed a saturable 'specific binding' of about 50% of the total binding, if measured at a lipoprotein concentration of 5 pg/ml.
TABLE III
The binding and uptake of the protein and cholestetyl ester moieties of LP A-I and LP A-I/A-II by HepG2 cells at 37°C
"'I-protein 'H-lipid a All values are cell-associated radioactivity expressed in % of added radioactivity, mean + S.E.M., n = 3). ' Significantly different from the value for LP A-I, P < 0.05. This finding is not dependent on the preincubation conditions. The cholesteryl ether-derived cell-associated radioactivity was higher than that derived from iodinated lipoproteins (expressed as % of the added radioactivity), indicating a preferential uptake of cholesteryl ether over apolipoproteins.
This selective uptake occured for both LP A-I and LP A-I/A-II.
The ratio cholesteryl ether uptake/apolipoprotein uptake ranged from 1.9 to 3.4.
Discussion
The differences between LP A-I and LP A-I/A-II resemble the known differences between HDL, and HDL,. Both LP A-I and HDL, have a relatively low protein content and a relatively high total cholesterol content. The esterification level is highest in LP A-I/A-II and HDL,. The observed protein contents of both LP A-I and LP A-I/A-II (55 and 60%, respectively) are higher than those reported for HDL isolated by ultracentrifugation [35] . HDL, and HDL, contain about 40% and 53% protein, respectively. The most likely explanation for these differences in protein content between the two isolation methods is 'stripping' of HDL-apolipoproteins during ultracentrifugation [36, 37] . Kunitake et al. [36] showed that 20% of the total apo A-I of human HDL was lost after one 24 h ultracentrifugation at high salt concentration. Cheung and Wolf [37] found that 14% of the apo A-I of LP A-I was found in the d 1 1.21 g/ml fraction after ultracentrifugation. About 9% of rat HDL apo A-I is lost during one ultracentrifugal step [38, 39] . The high protein content of LP A-I and LP A-I/A-II is a common finding after isolation of HDL-subfractions by immuno-affinity column chromatography. and total protein determination will probably result in more reliable data..
The isolated HDL-subfractions had average particle masses of about 380 and 270 kDa for LP A-I and LP A-I/A-II, respectively. The particle mass for LP A-I/A-II measured by us was higher than the values reported for HDL, [42, 43] . This again may be caused by the avoidance of ultracentrifugation (see above). Changes in apo A-I containing particles due to ultracentrifugation were described before [40, 44] . Vezina et al. [44] showed that apo A-I containing lipoproteins may have particle mass up to 815 kDa, if separated by gradient gel electrophoresis.
After prior ultracentrifugation, no apo A-I containing lipoproteins with average particle masses above 390 kDa could be detected anymore. In another study [40] , apo A-I containing particles, isolated by immuno-affinity chromatography, also had higher mean particle radii than HDL isolated by ultracentrifugation.
The subdivision of LP A-I in two subfractions (see Fig. 1 ) is also evident on gradient gel electrophoresis [45, 46] . In [45] the main band consisted of lipoproteins of approx. 300 kDa and the smaller band was about 164 kDa. The LP A-I isolated in our study was bigger: the major component has a particle weight of approx. 380 kDa. The mean particle size of LP A-I and LP A-I/A-II reported in part of the existing literature is somewhat smaller than the values obtained in the present study. This may be partly due to the method of analysis: measurements by gel filtration give slightly higher values for the radii of HDL particles, compared to gradient gel electrophoresis [47] . From our data we calculated mean particle radii of 6.2 nm for LP A-I and of 5.5 nm for LP A-I/A-II.
Using the same method, i.e., gel filtration, Cheung et al. [47] found similar results for LP A-I (5.7 to 6.5 nm) and higher values for LP A-I/A-II (6.0 to 6.3 nm) . Size measurements using the electron microscope showed apo A-I containing particles with a radius ranging from 5 to 6 nm [40] .
We find a molar ratio of apo A-I/ape A-II in LP A-I/A-II particles of 1.4 f 0.2. From a study of Ohta et al.
[41] a ratio of 1.5 for women and 1.6 for men can be calculated. James et al. [48] measured a ratio of 1.5 + 0.1. Cheung and Albers [45] isolated particles with a ratio of 2 and showed that ultracentrifugation had no effect on the apo A-I/ape A-II molar ratio. However, the major fraction of the LP A-I/A-II particles they isolate contains 2 molecules of apo A-I and l-2 molecules of apo A-II [49] . In our study at least 3 molecules of apo A-I and 2 molecules of apo A-II appear to be present on each LP A-I/A-II particle. For LP A-I, 2-4 apo A-I molecules per particle were proposed before [50, 51] . From the data obtained in this study we calculate that the average LP A-I particle may contain 7-8 molecules of apo A-I. This high number follows from the combination of a relatively high protein content as well as particle weight of the LP A-I subfraction.
Separate gel filtration of the two subfractions ( Fig. 1) . HDL,-binding to human adipocyte membranes decreased 92% after enrichment of HDL, with apo A-II. In our study with HepG2 cells LP A-I and LP A-I/A-II were both bound to about the same extent and cholesterylether uptake from HDL was comparable. In several studies using ligand blotting, apo A-I as well as apo A-II are able to bind to a receptor protein in membranes of various cell types, e.g., liver, adrenal cortex, kidney, fibroblasts, smooth muscle cells, macrophages and adipocytes [13, 57, 59] . In contrast, Schmitz et al. [60] state that only apo A-I is the ligand for the HDL receptor, since only anti-apo A-I was able to inhibit binding of HDL to peritoneal macrophages. Anti-apo A-II, anti-apo E and anti-apo C's did not inhibit HDL-binding.
A selective uptake of HDL-cholesteryl ether, compared to HDL-apolipoprotein, was observed in HepG2 cells, measured at 37°C confirming earlier reports [19, 61] . In our experiments
[3H]cholesteryl ether was used as a non-degradable label. Theoretically the '251 label will be released from the cells after degradation of the apolipoproteins.
However, no degradation could be measured during the short incubation periods used in our experiments (not shown). The selective uptake was higher for LP A-I than it was for LP A-I/A-II, but the differences were small. Our results do not support a specific role for apo A-II in the uptake of HDLcholesteryl esters.
The effects of CETP, secreted by HepG2 cells [62] , could influence our results. However, no CETP activity is detectable in the medium after 4 h of incubation (not shown). Recently, Rinninger and Pittman [19] showed that secreted CETP activity does not influence HDLcholesteryl ether uptake during short incubation periods.
This study describes for the first time the binding and uptake of HDL-subfractions, isolated by immunoaffinity chromatography, to HepG2 cells. No big differences in the binding or uptake of LP A-I and LP A-I/A-II were observed and no specific role of apo A-II in HDL-binding or uptake of cholesteryl esters was detected.
